mgrB mutations mediating polymyxin B resistance in Klebsiella pneumoniae isolates from rectal surveillance swabs in Brazil

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 11, 2016, Pages 6969-6972

  Aires, Caio Augusto Martins ^a   Pereira, Polyana Silva ^a   Asensi, Marise Dutra ^a   Carvalho Assef, Ana Paula D'Alincourt ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM; MEROPENEM; POLYMYXIN B; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE KPC-2, KLEBSIELLA PNEUMONIAE; PHOQ PROTEIN, BACTERIA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BRAZIL; DNA SEQUENCE; GENE INSERTION SEQUENCE; KLEBSIELLA PNEUMONIAE; MGRB GENE; MINIMUM INHIBITORY CONCENTRATION; MISSENSE MUTATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; RECTUM;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMYXIN B; RECTUM;

EID: 84994499298     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01456-16     Document Type: Article

References (27)

1. Ah YM, Kim AJ, Lee JY. 2014. Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents 44:8-15. http://dx.doi.org/10.1016/j.ijantimicag.2014.02.016.
2. Olaitan AO, Diene SM, Kempf M, Berrazeg M, Bakour S, Gupta SK, Thongmalayvong B, Akkhavong K, Somphavong S, Paboriboune P, Chaisiri K, Komalamisra C, Adelowo OO, Fagade OE, Banjo OA, Oke AJ, Adler A, Assous MV, Morand S, Raoult D, Rolain JM. 2014. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents 44:500-507. http://dx.doi.org/10.1016/j.ijantimicag.2014.07.020.
3. Kontopidou F, Plachouras D, Papadomichelakis E, Koukos G, Galani I, Poulakou G, Dimopoulos G, Antoniadou A, Armaganidis A, Giamarellou H. 2011. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients. Clin Microbiol Infect 17:E9-E11. http://dx.doi.org/10.1111/j.1469-0691.2011.03649.x.
4. Rodrigues Perez LR, Dias CG. 2016. Emergence of infections due to a polymyxin B-resistant KPC-2-producing Klebsiella pneumoniae in critically ill patients: what is the role of a previous colonization? Infect Control Hosp Epidemiol 37:240-241. http://dx.doi.org/10.1017/ice.2015.294.
5. Giacobbe DR, Del Bono V, Trecarichi EM, De Rosa FG, Giannella M, Bassetti M, Bartoloni A, Losito AR, Corcione S, Bartoletti M, Mantengoli E, Saffioti C, Pagani N, Tedeschi S, Spanu T, Rossolini GM, Marchese A, Ambretti S, Cauda R, Viale P, Viscoli C, Tumbarello M; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva). 2015. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study. Clin Microbiol Infect 21:1106.e1-1106.e8.
6. Gaspar GG, Bellissimo-Rodrigues F, de Andrade LN, Darini AL, Martinez R. 2015. Induction and nosocomial dissemination of carbapenem and polymyxin-resistant Klebsiella pneumoniae. Rev Soc Bras Med Trop 48:483-487. http://dx.doi.org/10.1590/0037-8682-0041-2015.
7. Olaitan AO, Morand S, Rolain J-M. 2014. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 5:643. http://dx.doi.org/10.3389/fmicb.2014.00643.
8. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161-168. http://dx.doi.org/10.1016/S1473-3099(15)00424-7.
9. Brazilian Committee on Antimicrobial Susceptibility Testing - (BrCAST) - EUCAST. 2016. Tabelas de pontos de corte para interpretação de CIMs e diâmetros de halos. Versão 6.0, 2016. http://brcast.org.br.
10. Clinical and Laboratory Standards Institute (CLSI). 2015. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 10th ed. CLSI document M07-A10. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
11. Lat A, Clock SA, Wu F, Whittier S, Della-Latta P, Fauntleroy K, Jenkins SG, Saiman L, Kubin CJ. 2011. Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest. J Clin Microbiol 49:1795-1798. http://dx.doi.org/10.1128/JCM.02534-10.
12. Girardello R, Bispo PJM, Yamanaka TM, Gales AC. 2012. Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results. J Clin Microbiol 50:2414-2418. http://dx.doi.org/10.1128/JCM.06686-11.
13. Perez LR. 2015. Evaluation of polymyxin susceptibility profile among KPC-producing Klebsiella pneumoniae using Etest and MicroScan Walk-Away automated system. APMIS 123:951-954. http://dx.doi.org/10.1111/apm.12438.
14. Gales AC, Castanheira M, Jones RN, Sader HS. 2012. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 73:354-360. http://dx.doi.org/10.1016/j.diagmicrobio.2012.04.007.
15. Jones RN, Guzman-Blanco M, Gales AC, Gallegos B, Castro ALL, Martino MDV, Vega S, Zurita J, Cepparulo M, Castanheira M. 2013. Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). Brazilian J Infect Dis 17:672-681. http://dx.doi.org/10.1016/j.bjid.2013.07.002.
16. Pereira PS, de Araujo CFM, Seki LM, Zahner V, Carvalho-Assef APD, Asensi MD. 2013. Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother 68:312-316. http://dx.doi.org/10.1093/jac/dks396.
17. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Barrett TJ. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 3:59-67. http://dx.doi.org/10.1089/fpd.2006.3.59.
18. Diancourt L, Passet V, Verhoef J, Patrick AD, Grimont PAD, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43:4178-4182. http://dx.doi.org/10.1128/JCM.43.8.4178-4182.2005.
19. Pitout JDD, Nordmann P, Poirel L. 2015. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59:5873-5884. http://dx.doi.org/10.1128/AAC.01019-15.
20. Andrade LN, Vitali L, Gaspar GG, Bellissimo-Rodrigues F, Martinez R, Darini ALC. 2014. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS-1, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J Clin Microbiol 52:2530-2535. http://dx.doi.org/10.1128/JCM.00088-14.
21. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. 2013. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785-796. http://dx.doi.org/10.1016/S1473-3099(13)70190-7.
22. Cannatelli A, Giani T, D'Andrea MM, Di Pilato V, Arena F, Conte V, Tryfinopoulou K, Vatopoulos A, Rossolini GM; COLGRIT Study Group. 2014. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother 58:5696-5703. http://dx.doi.org/10.1128/AAC.03110-14.
23. Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M, Türkoglu S, Nordmann P. 2015. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 70:75-80. http://dx.doi.org/10.1093/jac/dku323.
24. Cannatelli A, D'Andrea MM, Giani T, Di Pilato V, Arena F, Ambretti S, Gaibani P, Rossolini GM. 2013. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 57:5521-5526. http://dx.doi.org/10.1128/AAC.01480-13.
25. Martins WMBS, Nicoletti AG, Santos SR, Sampaio JLM, Gales AC. 22 July 2016. Frequency of BKC-1-producing Klebsiella species isolates. Antimicrob Agents Chemother http://dx.doi.org/10.1128/AAC.00470-16.
26. Britto XB, Plantinga NL, Lammens C, Poirel L, Nordmann P, Bonten MJ, Goossens H, Malhotra-Kumar S. 2016. Novel mgrB variants identified in colistin-resistant Klebsiella pneumoniae, abstr O594. Abstr 26th Eur Cong Clin Microbiol Infect Dis (ECCMID), 9 to 12 April 2016, Amsterdam, Netherlands.
27. Cheng YH, Lin TL, Pan YJ, Wang YP, Lin YT, Wang JT. 2015. Colistin resistance mechanisms in Klebsiella pneumoniae strains from Taiwan. Antimicrob Agents Chemother 59:2909-2913. http://dx.doi.org/10.1128/AAC.04763-14.